Antibody-evading virus vectors
US11976096B2 · kind B2 · utility
0Cited by
121References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 2023 |
| Grant date | May 7, 2024 |
| Priority date | — |
| Expiry date | Sep 26, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14171
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides recombinant AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the recombinant AAV capsid proteins. The disclosure also provides methods of administering the virus vectors and vims capsids of the disclosure to a cell or to a subject in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.